imatinib mesylate has been researched along with Lung Injury, Ventilator-Induced in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dudek, SM; Garcia, JG; Jacobson, JR; Letsiou, E; Naureckas, P; Rizzo, AN; Sammani, S | 1 |
Dudek, SM; Esquinca, AE; Garcia, JG; Jacobson, JR; Letsiou, E; Rizzo, AN; Sammani, S | 1 |
2 other study(ies) available for imatinib mesylate and Lung Injury, Ventilator-Induced
Article | Year |
---|---|
Differential and opposing effects of imatinib on LPS- and ventilator-induced lung injury.
Topics: alpha-Fetoproteins; Animals; Anti-Inflammatory Agents; Benzamides; Biomechanical Phenomena; Capillary Permeability; Cells, Cultured; Cytokines; Drug Evaluation, Preclinical; Endothelium, Vascular; Humans; Imatinib Mesylate; Lipopolysaccharides; Lung; Male; Mice, Inbred C57BL; Piperazines; Proto-Oncogene Proteins c-abl; Pyrimidines; Stress, Physiological; Ventilator-Induced Lung Injury | 2015 |
Imatinib attenuates inflammation and vascular leak in a clinically relevant two-hit model of acute lung injury.
Topics: Acute Lung Injury; Animals; Bronchoalveolar Lavage Fluid; Cell Nucleus; Disease Models, Animal; Endothelial Cells; Humans; Imatinib Mesylate; Inflammation; Lipopolysaccharides; Lung; Male; Mice, Inbred C57BL; Models, Biological; NF-kappa B; Phosphorylation; Protective Agents; Pulmonary Artery; Respiration, Artificial; Tumor Necrosis Factor-alpha; Ventilator-Induced Lung Injury | 2015 |